Dr. N.R.S. Ariyarathna, a distinguished Medical Officer in Anesthesia, has devoted nearly a decade to the field, working in prestigious institutions such as the National Hospital of Sri Lanka and the National Institute of Dialysis and Transplant. His extensive experience, particularly in anesthesia, emergency care and intensive care unit (ICU) settings, positioned him on the frontline during the COVID-19 pandemic, a time when the global healthcare system faced unprecedented challenges.
The Need for Innovation During the Pandemic
The COVID-19 pandemic exposed significant limitations in existing respiratory filtration systems. These systems were not properly equipped to handle the high demands of a global health crisis due to:
- Lack of efficiency: Existing filters could not meet the required standards for microbial filtration for prolonged ventilations during high patient loads.
- Disposable nature: Single-use products caused supply chain disruptions and frequent shortages.
- High costs: The expense per individual unit strained healthcare budgets.
- Disease spread during maintenance: Regular filter changes increased the risk of contamination and spread.
Other critical drawbacks included back pressure on patients, inability to monitor this pressure, poor filtration of large respiratory droplets, frequent filter blockages, and filtration efficacy dependent on flow and pressure.
Introducing the Microorganism Clearing Device (MCD)
Dr. Ariyarathna’s groundbreaking solution to these challenges is the Microorganism Clearing Device (MCD). Unlike traditional filters, the MCD is a microorganism-killing device equipped with two trapping systems and ten antimicrobial mechanisms. This innovative device overcomes the limitations of conventional filters with its ability to:
- Be reused multiple times.
- Minimize patient back pressure.
- Filter large respiratory droplets effectively.
- Reduce the likelihood of blockages.
- Key Features and Advantages
The MCD is designed to enhance infection control efficiency and adaptability.
Key features include:
- Adjustable efficacy: Settings can be modified based on the suspected microorganism.
- Scalable air filtration: The orientation can be changed depending on the volume of air that is needs to cleared.
Safety mechanisms includes advanced features such as:
- Peak pressure relief.
- Negative pressure protection.
- Positive pressure protection.
- Sealed antimicrobial chambers.
- Anti-spillage systems ensure patient safety and device reliability.
Monitoring capabilities: The device enables real-time monitoring of patient breathing, system patency, and expiratory pressure.
Tested Efficiency and Promising Results
The MCD has undergone rigorous testing by the Institute of Technical and Industrial Analysis (ITIA), demonstrating exceptional performance in clearing Staphylococcus aureus aerosols. Further studies across various settings have shown promising results, reinforcing its potential to transform critical care medicine.
Applications in Healthcare
- Intensive Care Units (ICUs)
- Quarantine centers
- Emergency treatment units
- General wards
- Recovery areas
- Outpatient Departments (OPDs)
- Ambulances and other transport teams.
The MCD promises to revolutionize infection control through:
Prevention of disease transmission: Protecting both patients and healthcare staff.
Cost reduction: Lowering healthcare expenses by reducing ICU stays and antibiotic use.
Combatting antibiotic resistance: Minimizing cross-infections and unnecessary antibiotic administration.
A Vision for the Future
Patented under number 21037 and evaluated by the National Medicines Regulatory Authority (NMRA), the MCD is undergoing feasibility studies in government hospitals. Future versions will incorporate advanced monitoring capabilities, including pressure and flow measurement via Wi-Fi and Bluetooth.
Dr. Ariyarathna’s invention has the potential to revolutionize infectious disease control globally, reducing patient morbidity and mortality while alleviating the financial burden on healthcare systems. As the world faces an increasing threat of pandemics, innovations like the MCD will play a crucial role in safeguarding public health.
For further inquiries, contact:
Dr. Ariyarathna
Mobile No. – 077 773 70 70
Email – [email protected]
